Moreover, promotion of axonal regeneration and oligodendrocyte growth and survival by LIF suggests its potential for reducing damage associated with central inflammatory demyelinating diseases such as multiple sclerosis [15-17]. The gene discussed is LIF; the disease is multiple sclerosis.